Filing Details
- Accession Number:
- 0001437749-16-030445
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-04-29 19:32:23
- Reporting Period:
- 2015-08-05
- Filing Date:
- 2016-04-29
- Accepted Time:
- 2016-04-29 19:32:23
- Original Submission Date:
- 2015-08-11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879682 | Viveve Medical Inc. | VIVMF | Electromedical & Electrotherapeutic Apparatus (3845) | 043153858 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1618243 | Patricia Scheller | 150 Commercial Street Sunnyvale CA 94086 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-08-05 | 526 | $1.05 | 135,662 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This amendment is being filed to amend the number of shares of common stock acquired by the reporting person in August of 2015 pursuant to a Rule 10b5-1 trading plan. Based on reports received from her broker, the reporting person initially reported two separate purchases of 526 shares of common stock at purchase prices of $0.8549 and $1.0451. The broker subsequently determined that only one purchase of 526 shares of common stock, at a price of $1.0451 per share, was completed and sent the reporting person a monthly statement showing only a single transaction at $1.0451. Therefore, the reporting person is filing this amendment to the Form 4 originally filed on August 11, 2015 to delete Row 1 of Table I in the original report and to correct the number of shares of common stock beneficially owned by her following the reported transaction.
- The purchases reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.